1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Vibostolimab–pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID6382]

Awaiting development [GID-TA11466] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 31264-MK7684A-for-Non-Small-Cell-Lung-Cancer-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)